Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Piper Sandler downgraded Kite Realty Group (NYSE:KRG) shares to Neutral from Overweight in a recent note as "we view the ...

For 2025, KRG provided NAREIT FFO guidance of $2 to $2.08 per share and core FFO guidance of $1.98 to $2.04 per share. Same-property NOI growth is projected at 1.75%, factoring in a 160-basis-point ...

Biotechnology Market OverviewThe Biotechnology Market report delivers crucial insights into the market's growth trajectory ...

Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...

Sartorius Stedim Biotech SA / Key word (s): Dividend Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting 07-Feb-2025 ...

Telefónica Tech has been ranked as the global leader in managed IoT connectivity by Kaleido Intelligence in its "Connectivity Vendor Hub: Compet ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

Biotech giant Gilead Sciences, Inc.’s (NASDAQ:GILD) $11.8 billion deal to buy CAR-T cancer therapy designer, Kite Pharma, Inc. (NASDAQ:KITE) has made two other leading... Abeona Therapeutics Inc ...